Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells

被引:44
|
作者
Hettinga, JVE
Lemstra, W
Meijer, C
Dam, WA
Uges, DRA
Konings, AWT
DeVries, EGE
Kampinga, HH
机构
[1] UNIV GRONINGEN,DEPT RADIOBIOL,NL-9713 BZ GRONINGEN,NETHERLANDS
[2] UNIV GRONINGEN,DEPT MED ONCOL,NL-9713 BZ GRONINGEN,NETHERLANDS
[3] UNIV GRONINGEN,DEPT HOSP PHARM,NL-9713 BZ GRONINGEN,NETHERLANDS
关键词
thermochemosensitization; cisplatin resistance; cisplatin accumulation; cisplatin-DNA adducts; adduct repair;
D O I
10.1038/bjc.1997.297
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, the mechanism(s) by which heat increases cis-diamminedichloroplatinum (cisplatin, cDDP) sensitivity in cDDP-sensitive and -resistant cell lines of murine as well as human origin were investigated. Heating cells at 43 degrees C during cDDP exposure was found to increase drug accumulation significantly in the cDDP-resisiant cell lines but had little effect on drug accumulation in the cDDP-sensitive cell lines. DNA adduct formation, however, was significantly increased in all cell lines studied. Furthermore, ongoing formation of platinum (Pt)-DNA adducts after the end of cDDP treatment was enhanced and/or adduct removal was decreased in heated cells, resulting in relatively more DNA damage remaining at 24 h after the end of cDDP exposure. Correlation plots with survival revealed weak correlations with cellular Pi accumulation (r(2) = 0.59) and initial Pt-DNA adduct formation (r(2) = 0.64). Strong correlations, however, were found with Pt-DNA adducts at 6 h (r(2) = 0.97) and 24 h (r(2) = 0.89) after the incubation with the drug. In conclusion, the mechanism by which heat sensitizes cells for cDDP action seems to be the sum of multiple factors, which comprise heat effects on accumulation, adduct formation and adduct processing. This mechanism did not seem to differ between cDDP-sensitive and -resistant cells, emphasizing the potential of hyperthemia to reduce cDDP resistance.
引用
收藏
页码:1735 / 1743
页数:9
相关论文
共 50 条
  • [1] Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells
    Marverti, Gaetano
    Guaitoli, Giambattista
    Ligabue, Alessio
    Frassineti, Chiara
    Monti, Maria Giuseppina
    Lombardi, Paolo
    Costi, Maria Paola
    AMINO ACIDS, 2012, 42 (2-3) : 641 - 653
  • [2] EFFECT OF MODULATION OF PROTEIN-KINASE-C ACTIVITY ON CISPLATIN CYTOTOXICITY IN CISPLATIN-RESISTANT AND CISPLATIN-SENSITIVE HUMAN OSTEOSARCOMA CELLS
    PEREGO, P
    CASATI, G
    GAMBETTA, RA
    SORANZO, C
    ZUNINO, F
    CANCER LETTERS, 1993, 72 (1-2) : 53 - 58
  • [3] Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry
    A. Fichtner
    H. Bohnenberger
    O. Elakad
    A. Richter
    C. Lenz
    C. Oing
    P. Ströbel
    S. Kueffer
    D. Nettersheim
    F. Bremmer
    World Journal of Urology, 2022, 40 : 373 - 383
  • [4] Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells
    Gaetano Marverti
    Giambattista Guaitoli
    Alessio Ligabue
    Chiara Frassineti
    Maria Giuseppina Monti
    Paolo Lombardi
    Maria Paola Costi
    Amino Acids, 2012, 42 : 641 - 653
  • [5] Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry
    Fichtner, A.
    Bohnenberger, H.
    Elakad, O.
    Richter, A.
    Lenz, C.
    Oing, C.
    Stroebel, P.
    Kueffer, S.
    Nettersheim, D.
    Bremmer, F.
    WORLD JOURNAL OF UROLOGY, 2022, 40 (02) : 373 - 383
  • [6] Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines
    K. Yamamoto
    Y. Kikuchi
    K. Kudoh
    I. Nagata
    Journal of Cancer Research and Clinical Oncology, 2000, 126 : 168 - 172
  • [7] lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
    Li, Qing
    Zhang, Juan
    Zhou, Juan
    Yang, Binglie
    Liu, Pingping
    Cao, Lei
    Jing, Lei
    Liu, Hua
    ONCOLOGY LETTERS, 2018, 15 (06) : 8363 - 8370
  • [8] Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines
    Yamamoto, K
    Kikuchi, Y
    Kudoh, K
    Nagata, I
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (03) : 168 - 172
  • [9] Higher induction of heat shock protein 72 by heat stress in cisplatin-resistant than in cisplatin-sensitive cancer cells
    Abe, T
    Gotoh, S
    Higashi, K
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1445 (01): : 123 - 133
  • [10] Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells
    Yu, Le
    Wu, William K. K.
    Gu, Chunping
    Zhong, Desheng
    Zhao, Xuyan
    Kong, Yi
    Lin, Qinghuan
    Chan, Matthew T. V.
    Zhou, Zhitao
    Liu, Shuwen
    ONCOTARGET, 2016, 7 (12) : 14693 - 14707